| 2022 |
| Developed Alogliptin benzonate(anti-diabetic drug) |
| Developed Edoxaban tosylate hydrate(anticoagulant) |
| Developed Apixaban(anticoagulant) |
| Developed Empagliflozin(Treatment for Diabetes mellitus type 2) |
| 2021 |
| Developed Lafutidine(Treatment for gastrointestinal disorders) |
| Developed Indigo carmine(Diagnostic dye) |
| Developed Duloxetine hydrochloride(Treatment for major depressive disorder) |
| Developed Donepezil base(Treatment for Alzheimer) |
| 2020 |
| Developed Febuxostat(Treatment for hyperuricacidemia) |
| Developed Ursodeoxychlolic Acid(Hepatic enhancer) |
| Developed Fenofibric Acid(Treatment for hyperlipidemia) |
| Developed Dapagliflozin Propandiol(Treatment for Diabetes mellitus type 2) |
| 2019 |
| Developed Mirabegron(Treatment for overactive bladder) |
| Developed Aripiprazole(Treatment for schizophrenia) |
| Developed Peramivir(Antiviral drug) |
| Developed Donepezil Hydrochloride(Treatment for Alzheimer) |
| 2018 |
| Antihyperlipidemic Agent - Pitavastatin Ca (Development Completion) |
| Overactive Bladder Therapeutics - Solifenacin (Development Completion) |
| Anticoagulant - Dabigatran (Development Completion) |
| Antihyperlipidemic Agent - Fenofibrate (Development Completion) |
| Antidiabetic - Dapagliflozin (Development Completion) |
| Mucolytics Agent - Erdosteine (Development Completion) |
| Non-Steroidal anti-inflammatory druge/NSAIDs - Celecoxib (Development Completion) |
| Gastroesophageal reflux disease - Dexlansoprazole (Development Completion) |
| 2017 |
| Immunosuppressant - Azathioprine (Development Completion) |
| Antipeptic ulcer Drug - Polaprezinc (Development Completion) |
| Antiplatelet Agent - Ticagrelor (Development Completion) |
| Reflux Esophagitis - Esomeprazole Magnesium Trihydrate (Development Completion) |
| 2016 |
| Antidiabetic - Vildagliptine (Development Completion) |
| Antidiabetic - Sitagliptin Hydrochloride Hydrate (Development Completion) |
| Diabetic Neuritis Agent - R-thioctic Acid Tromethamine (Development Completion) |
| Digestive Organ Agent - Mosapride Citrate Hydrate (Development Completion) |
| 2015 |
| Antiarteriosclerotic agent - Ezetimibe (Development completion) |
| Diabetes medicine - Sitagliptin phosphate monohydrate (Development completion) |
| Hepatitis B medicine - Tenofovir disoproxil fumarate (Development completion) |
| Cerebral function improving agent - Choline alfoscerate (Development completion) |
| Digestive organ agent - Mosapride citrate hydrate (Development completion) |
|
|
